Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Liver Disease–Associated Glomerulopathies
Swetha R. Kanduri
, Yonatan Peleg
,
Shikha Wadhwani
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Liver Disease–Associated Glomerulopathies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatitis C Virus
100%
Liver
100%
Hepatitis B Virus
100%
Glomerulopathy
100%
IgA Nephropathy (IgAN)
75%
Glomerulonephritis
75%
B Hepatitis
50%
Cryoglobulinemic Glomerulonephritis
50%
Epidemiology
25%
Clinical Manifestations
25%
Antiretroviral Therapy
25%
Clinical Treatment
25%
Immunosuppression
25%
Aggressive Disease
25%
Disease Course
25%
Glomerular Disease
25%
Direct-acting Antivirals
25%
Number of Individuals
25%
Virus Hepatitis
25%
Review Update
25%
Hepatitis B Treatment
25%
Kidney Injury
25%
Patients with Liver Disease
25%
Membranous Nephropathy
25%
Membranoproliferative Glomerulonephritis
25%
Disease Trajectory
25%
Extrahepatic Manifestations
25%
Podocytopathy
25%
Cryoglobulinemic Vasculitis
25%
Asymptomatic Urinary Abnormalities
25%
Anti-CD20 Therapy
25%
Medicine and Dentistry
Glomerulopathy
100%
Glomerulonephritis
100%
Hepatitis B Virus
80%
Hepatitis C Virus
80%
Immunoglobulin A Nephropathy
60%
Urinary System
20%
Cohort Effect
20%
Liver Disease
20%
Immunosuppressive Treatment
20%
Disease Course
20%
Antiviral Therapy
20%
Kidney Injury
20%
CD20
20%
Antiviral Drug
20%
Membranous Glomerulonephritis
20%
Membranoproliferative Glomerulonephritis
20%
Cryoglobulinemic Vasculitis
20%
Diseases
20%